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Abstract
Purpose of the review Digital health technologies offer tremendous potential in increasing
access to services and augmenting existing services. Utilizing these technologies, how-
ever, poses new ethical considerations for clinicians, researchers, and healthcare organi-
zations. These issues have been particularly apparent recently with several public in-
stances of misuse of digitally available personal data. Responsibility for ethics is distrib-
uted among creators, end users, and purveyors which has meant that this aspect of digital
technology production and use tends to be thought of as someone else’s problem.
Recent findings In this overview, we discuss key ethical issues and dilemmas in order to drive
ethical implementation, future technology development, and potential formal and informal
regulation. Key considerations discussed include risk-benefit ratios, privacy and data security,
ethical development of digital mental health tools, ethical research processes, and informed
consent. Concrete recommendations are made for different stakeholders in digital mental
health.
Summary Digital mental health tools come with ethical considerations for the public, patients,
clinicians, and health services to feel confident in their use. It will be essential for all groups to
recognize their responsibilities and begin to shape frameworks for ethical development and
implementation.
Introduction
The promise of technology to revolutionize mental
health is surrounded by hype. As an example, the Acad-
emy of Medical Sciences described digital health as a
fast-developing technology that will “transform the way
that health and social care is delivered” [1]. This hype is
understandable as such a revolution is warranted. It is
recognized that it will not be possible in the near future
to address the burden of mental health through training
professionals alone, and even if we could, some people
might desire (or require) alternative modalities to re-
ceive mental health support. However, this hype also
serves to detract from potential drawbacks of the appli-
cation of technology to mental health. Mental health
technology comes with a responsibility to determine
appropriate ethical standards in the development, re-
search, and integration of these technologies into society
and clinical care. Doing so will require a careful review
of which existing standards are relevant for these tech-
nologies and should balance each issue or problem
alongside relevant benefits, cultural norms, and values.
In this treatment of ethics, we adopt both an aspira-
tional as well as a pragmatic approach. We are not
ethicists, but rather are mental health and mental health
services researchers who have extensive experience in the
digital mental health space and have worked with con-
sumers, developers, clinicians, healthcare organizations,
evaluators, and payers.
Our pragmatism starts with defining what we are
referring to by digital mental health. A narrow definition
would consider only technologies intended for those
who have a mental health diagnosis. Many products,
however, attempt to avoid liability by stating that they
do not provide medical advice, diagnosis, or treatment
and then proceed to offer content and tools that address
mental health issues. We, therefore, adopt a comprehen-
sive definition of digital mental health that includes all
technologies that provide treatment andmanagement of
mental health problems. This includes technologies that
address social, psychological, and biological factors that
contribute to mental health, such as apps, wearable
devices, and virtual reality products. We also do not
define mental health as only the presence or absence of
a mental health diagnosis but include emotional, psy-
chological, and social well-being that spans a continu-
um from flourishing to languishing [2]. Therefore, we
are pragmatic in that we recognize that the technologies
being advertised to people on the promise of mental
health benefits aremuch broader than those that directly
address mental health diagnoses, so our ethical guide-
lines must address this broader array of technologies.
We are aspirational in believing that ethical guide-
lines developed today could guide the development and
uses of technologies in the future. If we develop ethical
guidelines only in response to technology, we will likely
always be developing guidelines in the midst of
disasters—ineffective technologies pushed on unin-
formed consumers, data breaches, and failures of people
to seek effective care in the face of flashy alternatives.
Multiple ethical codes are relevant to this space in-
cluding those drawing from health professionals as well
as technology developers. First, ethical codes support the
development and application of digital mental health.
For example, the American Medical Association’s princi-
ples of medical ethics require that physicians “support
access to medical care for all people.” Similarly, the
General Principles of the American Psychological Asso-
ciation’s Ethics Code [3] includes the principle of Justice,
which indicates that services be made accessible to all.
Insofar as digital mental health meaningfully extends
the reach of services to those with more limited access,
incorporation of these technologies into practice is in-
herently part of our ethical obligation. Most important-
ly, however, these codes define acceptable behavior to
protect the client, especially in the context of power
differentials inherent in the client-clinician relationship.
We need to be careful not to develop and spread tech-
nologies because we think it is the right thing to do as
the “experts” without consideration of the most critical
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issues for those who will be affected by these technolo-
gies. In light of this, we have previously suggested four
simple Transparency for Trust (T4T) principles [4••]
which were published in May 2019. These are based
on patient and regulatory perspectives, recent systematic
reviews, and experimental studies (e.g., [1, 5–7, 8•, 9,
10•, 11, 12•]. These principles include privacy and data
security, development characteristics, feasibility data,
and benefits. They were developed in order to fill the
void on information to the consumer available at the
point of download where we know that consumers
trade-off information to make choices; e.g., they may
want strict privacy or they may choose apps with more
efficacy information.
The T4T principles are a starting point, but in this
paper, we comment on additional ethical concerns
that expand on these principles by highlighting other
areas that need to be addressed when considering the
design and use of technologies for mental health
purposes.
Regulatory issues
If clinicians are prescribing or recommending digital treatments, they need to
understand their efficacy and safety. Professional bodies such as the Food and
Drug Administration (FDA) in the USA and the National Institute for Care and
Health Excellence (NICE) in the UK have traditionally been a resource to
clinicians by evaluating efficacy and safety of pharmaceuticals and medical
devices and. In recent years, there has been movement towards these bodies
offering the same evaluations for digital mental health treatments.
But, digital mental health treatments challenge traditional medical regula-
tory structures. Digital mental health tools change regularly which raises the
question of what is being approved. For example, reSET, the first behavioral
health app approved by the FDA was approved based on evidence collected on
the web-based version of the treatment not the app itself [13]. Indeed, the
content within both platforms might be the same, but in general, people use
mobile apps differently than websites, with more frequent, shorter and poten-
tially less focused contacts [14]. New digital mental health tools are regularly
being released and some existing toolsmight disappear from themarket quickly
[15]. Some attempts to address this issue has been independent app review. The
UKNICE curates a health app library with in-depth reviews of the evidence, but
there are few apps available, and even fewer aimed at mental health. Review
organizations such as the non-profit PsyberGuide, a project of One Mind, and
the for-profit ORCHA, also provide reviews and guidance [16, 17], but even
though they can work at a faster pace, they still produce relatively few balanced
recommendations. An alternative approach to regulation is education of stake-
holders of key aspects such as the American Psychiatric Association’s App
Evaluation Framework [18•]. However, it is unclear whether education will
be sufficient to guide stakeholders to safe and effective products. We need
widely accepted and available information about what products work as well
as standardizations around issues such as expected use.
Privacy and data security
Privacy and data security have become a focus for us all but have always been of
interest to mental health service users [19]. We now know that there is no such
thing as a free Internet search or a free app. Even the founder of theworldwideweb,
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the Cambridge professor Sir Tim Berners-Lee, spoke out about this concern on the
web’s 28th birthday in 2018. He pointed out that companies allow us to use free
content in exchange for our personal data [20]. Ethical codes for dealing with
personal data have been developed into laws such as the European Union General
Data Protection Regulation (GDPR) which is based on the idea that individuals
own their data and must give consent to any uses. In the USA, data that reaches
covered entities falls under the Health Insurance Portability and Accountability Act
(HIPAA), but data that an individual maintains outside of a health system does
not. Breaches of the GDPR rules can result in large fines. Specific regulations are
likely necessary to protect health data coming from personal devices and, specifi-
cally, to create standards around data storage and transmission to ensure that
people’s mental health data are not used for purposes that they do not intend.
In many cases, we have no access to these data and cannot pick and choose
who has access to it. Information about these rules is presented to individuals in
long and complex Terms and Conditions statements and you need to accept
them before you can access the service. Although we are sometimes given the
option of deciding whether advertisers have our data, this is a blanket question.
We do not have the opportunity to allow some and not others. Service users
have always raised privacy as an issue for providing data that will be available to
others [21–23]. The questions from the T4T principles [4••] are as follows: (1)
what data leaves the device?; (2) how is that data stored? (e.g., de-identified,
encrypted); and (3) who will have access to that data? It should be clear what, if
any, data is being sold, to whom, and what steps are taken to ensure that users
cannot be identified by that data.
Monitoring and assessing risks and benefits
The recommendation of health products is often based on a determination of
the anticipated benefit relative to the potential risk. Traditionally, benefits and
risks have been determined based on clinical trials and clinical evidence.
Empirical studies are used to determine that an intervention works and to help
identify potential concerns that might contraindicate its use. Once deployed,
post-market surveillance is used to monitor the safety of a product. Digital
tools, however, provide both new challenges and offer new affordances. As
mentioned earlier, digital tools evolve over time. Compared with drug formu-
laries which are consistent, apps undergo iterative changes to address bugs and
make feature updates. In fact, app updates might be one way to maintain the
quality and benefits from a product [24]. Benefits and harms may then change
over time which will require continuous data collection and digital tools can
offer this monitoring.
In any assessment, the benefits must be balanced against the risks, so health
benefits should be clear before the user downloads a digital tool. This is not
always the case and some advertising is certainly misleading. Any digital tool
should undergo safety testing and if it purports to provide a benefit, it should be
clear what that benefit is and who it has benefitted. For a balanced understand-
ing, information on whether the technology has been used in its intended
population with user (clinician and/or patient) satisfaction and engagement,
whether it has been used in its intended setting (i.e., commercial marketplace,
adjunct to in-person specialty treatment, primary care) and what types of
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support have been required to implement it in research. This last issue is vital as
paying participants for use, providing back-up services, or a coach may not be
available in the wider world but may be acceptable in research practice. Most
interventions will go through at least one randomized controlled trial and
typically, they report an effect size. This is probably not understood by many
and so designers should provide clarity so that users and clinicians can under-
stand the number of people who benefit and by how much, as well as the
number of people who do not benefit. No digital tool will help everyone and if
individuals do not receive benefit then they should at least understand that
others had the same experience. They will then not attribute the problem to
some individual failing which may add to the severity of their mental health
problems. The three T4T questions for apps from Wykes and Schueller [4••]
related to risks and benefits are (1) what is the impact on the health condition,
(2) what percentage of users received either no benefit or deteriorated, and (3)
are there specific benefits that outweigh any costs?
Including diverse panels of end users in development
The intended end users should be present at the beginning of the development and
design process. Often this step is completely missed until the tool has been
developed and designers rely at best on current evidence on intervention gaps
and clinician views. It is vital, however, that ethical and responsible developmental
practices include the target audience in development if the digital tool is to provide
themost benefit. This principle would also be likely to increase engagement which
is a particular problem and which means that fewer people actually receive a
benefit. For instance, some toolsmeant to support those with depression are tested
on groups with low-level symptoms (e.g., distressed undergraduates). The range
and depth of problems will not be the same and so this design process risks
potential harm (see [25] for a feasibility and usability model study). T4T principles
suggest three simple questions: (1) how were target users involved in the initial
design, (2) howwere target users involved in usability evaluations, (3) has usability
been independently evaluated?
Research
Research ethics boards oversee research carried out on digital health. Despite
differences across countries, these ethics boards generally do not have much
expertise in overseeing the ethical issues of this type of research. Given the
newness of the field and the unique ethical considerations that exist, appropri-
ate representation of digital health researchers on these boards will be essential
to supporting and directing ethically sound research advancements.
As an example, one common ethical concern in digitalmental health research is
the appropriate response to data collected outside of the context of study visits. In a
standard clinical trial of cognitive-behavioral therapy or an antidepressant medica-
tion, most data is collected in study visits that occur during workday hours when
study staff are adequately prepared to respond to indications of participant risk. For
example, if a participant reports suicidal ideation at a study visit, the study team can
and should do a thorough, in-person risk assessment to determine whether
voluntary or involuntary hospitalization is necessary.
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In digital mental health research, study assessments are often administered
remotely via a smartphone or an online portal and participants can often choose
when they want to complete these assessments. If a participant completes such an
assessment at 11 pmon a Saturday evening and indicates suicidal ideation, should
the researcher be expected to initiate a follow-up assessment that evening? If so,
what is the appropriate course of action if the researcher cannot reach the partic-
ipant via phone? Neither of these questions would come up in a clinical trial in
which assessments were only conducted during study visits; however, just because
we are not collecting assessments between study visits does not mean that partic-
ipants were not experiencing suicidal ideation at these times. Assessing more
frequently and remotely using technology has the benefit of offering a complete
andmore nuanced picture of the participant’s struggles withmental illness and can
also introduce questions about risk management and participant safety.
All too often, these questions are dealt with by simply limiting assessments to
in-person or phone visits or excluding items involving issues such as suicidality.
While this skirts the ethical concerns around follow-up assessment during non-
workday hours, it could be considered unethical insofar as it involves missing an
opportunity to understand how the technologymay be affect participants and how
it will have an impact on future patients. It also involvesmissing an opportunity to
assess and intervene on that participant’s suicidal ideation, whether that interven-
tion is an automated message with a helpline number or a follow-up call from a
study clinician. Another option for dealingwith these questions has been to require
an on-call clinician to respond to any assessment alerts (e.g., reported suicidal
ideation (SI)) within some time period, say 30 min. While this may seem appro-
priate, it can also make the technology less feasible to use in real-world contexts
and, for the same reasons, it can make conducting digital mental health research
prohibitively expensive. Again, the limits this can place on relevant scientific
discovery may also raise ethical questions.
Risk monitoring is just one example of ways in which digital mental health
researchmay differ from standard clinical trials. Other issues related to data security
(e.g., the fact that in digital health research emails are often used for correspondence
instead of mail or phone calls or that third parties, like the company who devel-
oped the app, will likely have access to personal health information (PHI) like
participant phone numbers); end-user license agreements (which are often re-
quired for use of products developed by companies, but may need to be waived
for a research study); and communicating the degree of clinician monitoring (e.g.,
participants may assume that because a study is being conducted at a clinic where
they are receiving care that the data will be transmitted to and monitored by their
clinician) also pose challenges specific to digital health research. Establishing
guidelines for Ethical Review Boards such that these challenges are managed
ethically in ways that protect research participants and allow for scientific innova-
tion will be important as research in this domain expands.
Informed consent, terms of services, and end-user license
agreements
In clinical research and clinical practice, potential consumers or participants
complete a consent process to become informed participants in the decision to
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complete the research project or treatment. For software, consumers often agree
to either end-user license agreements or terms of services to indicate their rights
for using the software and rules they agree to for its use. It is worth noting that
the goals of these processes are quite different with informed consent requiring
individuals to be able to understand the information to make an informed
decision. Terms of services and end-user license agreements are legal documents
that serve to protect the developer and their products and ensure the consumer
uses the products in expected ways.
Although informed consent documents are often reviewed and approved by
regulatory bodies such as NHS Ethics or Institutional Review Boards, similar
processes do not exist for terms of services and end-user license agreements for
digital mental health products. As legal documents, the primary question is
whether they are sufficient to stand up in legal processes. Such documents could
be improved by being shorter and simpler and having checks on relevant
understanding. A recent review found that many digital mental health products
lack such policies and those that exist are often unacceptable (O’Loughlin,
Neary, Adkins, & Schueller, 2019). As such, better attempts to inform potential
consumers about the limits, risks, and potential benefits should be provided in
these products.
Recommendations
1. Developers need to design systems that are safe, trustworthy, and aligned
with the values and preferences of those who are influenced by their actions.
They need to be aware of their hidden assumptions when they build systems
on available data. The resulting digital tool may have unintended conse-
quences, particularly, the potential to amplify gaps in healthcare. They
therefore need to be able to abide by the Heston criterion that whatever is
built is “best for people” and we would add that this is best for health
systems in the long run too. Service user/consumer involvement should be
present from the beginning and as such, developers need to be more
collaborative in their efforts to engage their target audiences.
2. Researchers ought to consider not just their university or health services
ethics committee rules but also the standards more broadly across the field.
Establishing broad guidelines for ethics committees around issues such as
data security standards, risk assessment, and response, conducting informed
consent, and involving digital health researchers on institutional review
boards will be essential to performing ethical, cutting-edge research. All
research ethics boards will need help to develop the expertise to evaluate
and advise on such projects and ultimately that help will fall on the
researchers to educate these boards. The Connected and Open Research
Ethics (CORE) Initiative at the University of California, San Diego, is one
example of a consolidated effort related to digital health research, but we
need more efforts to facilitate moving the field forward.
3. Cliniciansmust have clear guidance from professional and regulatory bodies
on what technologies are safe and effective as well as when they are appro-
priate to use. Increasingly, opportunities will have to be made available for
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clinicians to receive training and education on the uses of technology in
mental health care. This has been highlighted in a number of recent reports
[1, 26, 27]. Effective treatments may be standalone web-based or app-based
technology and obviously clinicians need to be aware of their effectiveness
of and the groups of individuals for whom they are appropriate. Other
digital technologies may be blended with traditional care and, if so, clini-
cians need to be trained to integrate technology effectively into their work.
4. Regulators and governments.We know that technology in health is disruptive.
It will take time to transform the way we work and the hype to attract
investors or an audience will need some regulation. The Federal Trade
Commission has stepped in to remove misleading advertising such as that
for Lumosity [28] which was marketed as helping people improve their
brain power. Clinician-researchers in digital mental health, especially those
not motivated by a specific commercial product, should be involved in
developing regulatory guidelines, approving products, and setting forth
models of appropriate integration of these products into clinical care.
5. Individuals must be made aware of where and how they can access technol-
ogies that may be helpful for them in managing their mental health.
Additionally, there must be plain language explanations of possible bene-
fits, how these have been tested, and what risks to privacy or health may be
involved in using each technology. Individuals are ultimately responsible
for the use of such tools, but such use needs to be predicated on developers,
clinicians, and systems ensuring the proper supports exist for successful use.
6. Digital platforms such as Apple iTunes store andGooglePlay have so far taken
a libertarian approach to selling apps but they toowill probably come under
some pressure to adopt ethical principles for selling something described as
a “health ormental health app.”We have described our T4T principles in an
earlier paper, which we think they should adopt at the point of download.
Platforms also need to consider their ethics for developing and monitoring
digital technologies. Social media platforms have now begun to address
their responsibility for content on their platform and one important con-
sideration is its mental health impact.
Conclusions
The very fact that this is a fast-developing area suggests that we do not know
what the problems are going to be in the future. But we can specify in advance
what we expect digital technology to do in healthcare so that their design
options are transparent. A number of issues need to be considered by everyone
in the digital technology field and, in particular, for the fast-growing field of
digital mental health care and services.
1. Social and cultural issues may be subtle and affect how technology is used in
different social strata and different countries. We must be sure that devel-
opments or use of digital technology does not accentuate existing digital
divides [1, 19, 29].
2. Data manipulationwhich includes the use of personally identifiable data, but
most often is about algorithms for Big Data can affect the service, the
intervention, or the interactions between them. For instance, a non-
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transparent application of an algorithm might have unintended (or
intended) effects on the provision of services by providingmore face-to-face
time with those likely to recover quickly rather than harder cases which will
absorb more clinic time. This would have the intended consequence of
allowing a service to meet targets for efficiency and may even suggest that it
was more effective, but neither would be true.
3. Complexity occurs because there are multiple producers and users who may
never be in contact, and on top of this, there are new uses for old technology
that may never have been envisaged by the original producer. This distrib-
utes responsibility through a network with no clear understanding of what
each node is responsible for. It is like Homer Simpson’s manifesto when he
ran as Commissioner for the Sanitation Department, “Can someone else do
it?” The assumption that it is someone else’s job has the potential for
allowing important problems to fall through the net.
In sum, the interdisciplinary nature of the field of digital mental health
introduces challenges of colliding ethical traditions and responsibilities. We
identified and discussed some of these issues and emphasize the need for
stakeholders to work together to address these issues. We do not pretend that
this will be simple, but we believe that much more can be done now to ensure
that ethical guidelines are followed.
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